CHOP Cancer Researchers Win 2021 AACR Team Science Award
Published on
The award was presented to the St. Baldrick’s Foundation-Stand Up 2 Cancer Pediatric Cancer Dream Team, co-led by CHOP, at the annual AACR conference.
Refractory Neuroblastoma Program News and Updates
1 - 10 of 18
CHOP Researchers Awarded Crazy 8 Grant from Alex’s Lemonade Stand Foundation
Published on
CHOP researchers will receive funds to discover a new drug that targets MYCN, a transcription factor involved in some pediatric cancers.
Yael Mossé, MD, Featured by the Conquer Cancer Foundation
Published on
The CHOP physician-researcher’s investigation into cause of and treatment for neuroblastoma has been supported by Conquer Cancer grants.
Children’s Hospital of Philadelphia Announces Endowed Chair in Pediatric Neuroblastoma Research
Published on
CHOP recipient, physician-scientist Dr. Yael Mossé, is innovating targeted, less toxic therapies for cancer affecting mostly infants and young children.
Dr. John Maris Receives QED Award to Develop Novel Treatment for Neuroblastoma
Published on
A CHOP research leader received an award from the University City Science Center to help develop a new T-cell based treatment for a childhood cancer.
Working to Improve Cure Rates for High-risk Neuroblastoma
Published on
Researchers at CHOP are working to discover the fundamental mechanisms that subvert normal neural development and orchestrate neuroblastoma tumorigenesis, and then to translate this knowledge into more effective and less toxic therapies.
Remembering Dr. Giulio John D'Angio
Published on
Watch a memorial tribute to Dr. Giulio John D'Angio, pioneer in the treatment of children's cancers.
Pediatric Cancers Differ from Adult Cancers, and Need Different Treatment Plans, Say CHOP Experts
Published on
A new study finds important differences in how cancers develop in children as compared to adults, proving the concept that childhood cancers are not "small adult tumors."
CHOP Researchers Identify Potential Target in Treating High-risk Childhood Cancers
Published on
Oncology researchers studying high-risk children’s cancers have identified a cell surface protein that may offer an important target for immunotherapy, a treatment that has the potential to zero in on cancer cells without harming healthy cells.
Advances in Pediatric Cancer Care
Published on
In a special airing on CBS Sunday Morning, Dr. Adamson details new therapies that are helping more children be cured.